Market News AIOpen the app

QNTM stock news · Quantum BioPharma Ltd.

Stories about Quantum BioPharma Ltd. (QNTM) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for QNTM

Follow Quantum BioPharma Ltd. (QNTM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for QNTM
Free on the App Store and Google Play, or on the web.
  1. Oct 6, 2026, 5:54 AM ET · Market

    Thermo Fisher will help Quantum Biopharma test a new drug for multiple sclerosis.

    Good for QNTM

    Quantum BioPharma's Lucid-MS is moving toward a Phase 2 trial with Thermo Fisher's support. This advances testing, but the drug still needs to show it is safe and works.

  2. Aug 10, 2026, 6:42 AM ET · Trial

    FDA grants approval to Quantum BioPharma for Phase 2 clinical trials of its multiple sclerosis treatment.

    Good for QNTM

    Quantum BioPharma has received FDA clearance for its investigational drug Lucid-MS, allowing it to proceed with Phase 2 clinical trials for multiple sclerosis. This milestone is expected to enhance investor confidence and could lead to increased stock performance as the company addresses a significant medical need in the MS treatment landscape.